You are here: Published Weight Loss Studies > Drug Treatment Studies > Topiramate (Topamax)
|
Index of published clinical studies related to Fluoxetine (Prozac), off-label use for weight loss
|
Research articles of clinical studies are listed by publication date, starting with the latest. Click on the title to view the abstract.
Well-designed clinical studies related to Fluoxetine (Prozac), off-label use for weight loss
Rapid response to treatment for binge eating disorder. [2006 Jun]
Binge eating disorder in obesity: comparison of different therapeutic strategies. [2005 Sep]
Cognitive behavioral therapy and fluoxetine as adjuncts to group behavioral therapy for binge eating disorder. [2005 Jun]
Efficacy of cognitive behavioral therapy and fluoxetine for the treatment of binge eating disorder: a randomized double-blind placebo-controlled comparison. [2005 Feb 01]
Metabolic effects of fluoxetine in obese menopausal women. [2000 May]
Fluoxetine improves insulin sensitivity in obese patients with non-insulin-dependent diabetes mellitus independently of weight loss. [1997 Feb]
The addition of dexfenfluramine to fluoxetine in the treatment of obesity: a randomized clinical trial. [1996 Nov]
Usefulness of fluoxetine in obese non-insulin-dependent diabetics: a multicenter study. [1996 Jul]
Long-term effects of fluoxetine on glycemic control in obese patients with non-insulin-dependent diabetes mellitus or glucose intolerance: influence on muscle glycogen synthase and insulin receptor kinase activity. [1995 Dec]
Efficacy and safety of long-term fluoxetine treatment of obesity--maximizing success. [1995 Nov]
Serotoninergic manipulation, meal-induced satiety and eating pattern: effect of fluoxetine in obese female subjects. [1995 Jul]
Fluoxetine increases resting energy expenditure and basal body temperature in humans. [1995 May]
A study of fluoxetine in obese elderly patients with type 2 diabetes. [1995 May]
Comparison of fluoxetine and placebo in the treatment of obesity. [1995]
Evaluating success of weight loss programs, with an application to fluoxetine weight reduction clinical trial data. [1994 Nov]
Pattern analysis method for assessing successful weight reduction. [1994 May]
No specific effect of fluoxetine treatment on fasting glucose, insulin, lipid levels, and blood pressure in healthy men with abdominal obesity. [1994 Mar]
Fluoxetine: a randomized clinical trial in the treatment of obesity. [1994 Mar]
Fluoxetine in the treatment of obese type 2 diabetic patients. [1994 Jan-Feb]
The effect of fluoxetine on body weight, body composition and visceral fat accumulation. [1993 May]
Fluoxetine: a randomized clinical trial in the maintenance of weight loss. [1993 Mar]
A randomized double-blind clinical trial of fluoxetine in obese diabetics. [1992 Dec]
An assessment of the thermogenic effects of fluoxetine in obese subjects. [1992 May]
Fluoxetine treatment of the obese diabetic. [1992 Mar]
Clinical studies with fluoxetine in obesity. [1992 Jan]
Fluoxetine's effect on weight loss in obese subjects. [1991 Aug]
Effect of serotonin re-uptake inhibition by fluoxetine on body weight and spontaneous food choice in obesity. [1991 Mar]
A double-blind, placebo-controlled trial of fluoxetine plus behavior modification in the treatment of obese binge-eaters and non-binge-eaters. [1990 Jul]
Other clinical studies related to Fluoxetine (Prozac), off-label use for weight loss
Comparison of combinations of drugs for treatment of obesity: body weight and echocardiographic status. [2006 Dec 05]
Obesity: new perspectives and pharmacotherapies. [2006 Sep-Oct]
Daily high doses of fluoxetine for weight loss and improvement in lifestyle before bariatric surgery. [2005 Sep]
Pharmacotherapy for obesity. [2005]
Meta-analysis: pharmacologic treatment of obesity. [2005 Apr 05]
Diabesity: are weight loss medications effective? [2005]
Serotonin (5-HT) drugs: effects on appetite expression and use for the treatment of obesity. [2005 Mar]
Pharmacotherapy for weight loss in adults with type 2 diabetes mellitus. [2005 Jan 25]
A study of electrical conductance of meridian in the obese during weight reduction. [2004]
Psychotropic drugs in the treatment of obesity: what promise? [2004]
Efficacy of pharmacotherapy for weight loss in adults with type 2 diabetes mellitus: a meta-analysis. [2004 Jul 12]
Pharmacological approaches in the treatment of binge eating disorder. [2004 Apr]
Novel anti-obesity drugs. [2000 Jun]
Open treatment of overweight binge eaters with phentermine and fluoxetine as an adjunct to cognitive-behavioral therapy. [2000 Nov]
Fluoxetine treatment for weight reduction in steroid-induced obesity: a pilot study in myasthenia gravis patients. [1999 Jan]
Sertraline enhances the effects of cognitive-behavioral treatment on weight reduction of obese patients. [1996 Dec]
Medicating the obese patient. [1996 Dec]
Dexfenfluramine. An updated review of its therapeutic use in the management of obesity. [1996 Nov]
[The effect of fluoxetine on insulin resistance in non diabetic obese patients] [1995 Aug]
Fluoxetine induced weight loss: a pilot study in postpartum women. [1995]
Long-term weight loss: the effect of pharmacologic agents. [1994 Nov]
Baseline predictors of success when comparing two treatments. [1994 Jul]
Fluoxetine therapy in obese diabetic and glucose intolerant patients. [1992 Dec]
Appraisal of the clinical value of serotoninergic drugs. [1992 Jan]
Use of a serotonin re-uptake inhibitor, fluoxetine, in the treatment of obesity. [1987]
Fluoxetine-induced weight loss in overweight non-depressed humans. [1987]
|
